title: [Clinical and neurophysiological study of the efficacy of adaptol in the treatment of emotional burn-out].
abstract: The study aimed at therapeutic effect of adaptol on burn-out syndrome. Authors examined 32 patients aged from 25 to 45 years. Adaptol was prescribed in day dose 1500 mg during 60 days. Clinical, psychological and electroencephalographic study (EEG) was conducted before and after the treatment course. The data of adaptol positive influence on the basic clinical symptoms (reduction of asthenic and anxiety scores) is obtained. The analysis of EEG results allows to draw conclusions on normalisation of brain functional activity after therapy.
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Surushkina
authors.forename: I S
authors.initials: IS
authors.lastname: Nikishena
authors.forename: E A
authors.initials: EA
authors.lastname: Iakovenko
authors.forename: A V
authors.initials: AV
authors.lastname: Rozhkova
authors.forename: T I
authors.initials: TI
authors.lastname: Anisimova
mesh_terms: D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D001611:Beta Rhythm; D001736:Biureas / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000503:physiopathology; D002055:Burnout, Professional / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D016896:Treatment Outcome
chemical_list: D001736:Biureas; C015979:mebikar